Q: Does HIPAA allow a covered entity or business associate to use a cloud services provider (CSP) that stores protected health information (PHI) on servers outside the United States?
Following the public health emergency (PHE) declaration in the state of California due to wildfires, HHS released a bulletin covering HIPAA waivers and disclosures during emergency situations.
Q: It’s often convenient to pass along a list of resources to patients, but we’ve found that this may not be the best approach when working with patients battling substance use disorders. What are your suggestions for providing help to these patients?
Q: We have patients being admitted for novel coronavirus (COVID-19) and most of them have a laundry list of various manifestations and complications. Do all manifestations and complications need to be reported in ICD-10-CM?
CMS extended the education and operations testing period for the Appropriate Use Criteria (AUC) program for advanced diagnostic imaging through 2021. The education and operations testing period, which started January 1, 2020, was slated to close at the end of the year.
The Office for Civil Rights (OCR) issued amended guidance on August 24 regarding covered entities (CE) and health plans contacting patients who have recovered from the novel coronavirus (COVID-19) to inform them about donating blood to help other COVID-19 patients.
Q: If a person has a history of substance abuse, but at the time of admission appears to be of sound mind, is that patient’s personal representative still entitled to receive information about the patient’s treatment and status?
Q: As utilization review case managers, we are often tasked with assessing our hospital's risk for novel coronavirus (COVID-19) denials. What are the most important measures we should be examining?
